Portfolio valuations (AASB 13 Fair Value Measurement)

Why Portfolio Valuations Matter

When your fund holds investments in private companies — whether equity, debt, convertible instruments, or structured securities — Australian Accounting Standards require a defensible determination of Fair Value at each reporting date. That value directly drives what you report in your fund’s audited financial statements, what you communicate to investors in periodic statements, and what determines management fees, performance fees or carried interest calculations, and performance metrics like IRR and TVPI.

Getting this wrong carries real consequences: overstating portfolio values inflates reported performance and can trigger ASIC enforcement action, investor disputes, and breaches of the responsible entity’s or trustee’s duties; understating values shortchanges fund economics and misrepresents returns. With ASIC continuing to flag valuation of unlisted assets as a surveillance priority for private market funds and superannuation trustees, the scrutiny on private fund valuations has never been higher.

Working with an accredited business valuation specialist who understands AASB 13’s fair value framework — and how auditors and regulators evaluate Level 3 measurements — is the single most important step to protect your fund, your investors, and your reputation.

InteleK’s team of accredited valuation specialists delivers audit-ready, AASB 13-compliant portfolio valuations built specifically for private equity, venture capital, growth equity, credit, and multi-strategy funds — providing defensible conclusions of fair value from both a sophisticated financial and regulatory perspective.

Book a Free Consultation Call

One of InteleK´s accredited appraisers is available to listen to your story and answer any questions you may have.

Portfolio valuations (ASC 820 Fair Value Measurement)

AASB 13 — The Fair Value Framework for Portfolio Investments

AASB 13 (Fair Value Measurement) defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. For investment funds, this means every portfolio company investment must be measured at its exit price — not what the fund paid, not what it hopes to receive, but what a knowledgeable, willing market participant would pay today.

When Portfolio Valuations Are Required

Portfolio valuations under AASB 13 are required whenever a fund reports financial results under Australian Accounting Standards. In practice, this means:

Annual audited financial statements — Required for virtually all institutional-quality funds and subject to external audit review of every material fair value measurement. Registered managed investment schemes must lodge audited financial reports with ASIC under Chapter 2M of the Corporations Act.

Periodic unit pricing and investor statements — Most constitutions and information memoranda require regular NAV or unit price reporting, which necessitates updated fair value estimates for all material holdings. Registered schemes must also comply with ASIC’s unit pricing guidance (RG 94).

Interim reporting triggers — Material events such as new financing rounds, significant operational changes, or market dislocations may require interim fair value updates between regular reporting periods.

Fund-of-funds and secondary transactions — Investors acquiring or selling fund interests rely on reported NAVs that are anchored to AASB 13-compliant portfolio valuations.

The Fair Value Hierarchy Applied to Portfolio Investments

AASB 13 establishes a three-level hierarchy that prioritises the inputs used in valuation:

Level 1 — Quoted prices in active markets for identical investments. Applies to listed securities held by the fund with sufficient trading volume.

Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar securities, recent transaction prices in less active markets, or market-corroborated inputs like yield curves and credit spreads. Applies to certain syndicated loans, traded debt, and securities with observable but imperfect market data.

Level 3 — Unobservable inputs reflecting the fund’s own assumptions about what market participants would use. This is where the vast majority of private equity, venture capital, and credit fund investments are classified — requiring sophisticated valuation models, well-documented assumptions, and the highest degree of audit scrutiny.

Level 3 measurements are the primary focus of auditor testing, ASIC audit inspection findings, and ASIC surveillance of private market funds. InteleK’s portfolio valuations are engineered from the outset to satisfy the documentation and transparency requirements that auditors and regulators expect for every Level 3 fair value measurement.

Equity Investment Valuations

Valuing equity investments in private portfolio companies is the core of most fund valuation programs. Unlike listed shares with readily available market prices, private company equity requires the valuation specialist to estimate enterprise value and then allocate that value across the capital structure to determine the fair value of the specific securities held by the fund.

Enterprise Value Determination

The starting point for any equity valuation is estimating the total enterprise value of the portfolio company. InteleK applies the valuation approaches most appropriate for the company’s stage, industry, and available data:

Market Approach — Uses valuation multiples (EV/Revenue, EV/EBITDA, EV/Gross Profit) derived from comparable listed companies or comparable M&A transactions, applied to the portfolio company’s financial metrics. This is the most widely used approach for growth-stage and mature portfolio companies with measurable financial performance.

Income Approach (DCF) — Projects the portfolio company’s future cash flows and discounts them to present value at a rate reflecting the risk of those cash flows. Most relevant for companies with predictable revenue streams or where the market approach does not capture company-specific growth dynamics.

Calibration to Recent Transactions — When the fund or other investors have recently transacted at an arm’s-length price, AASB 13 and the 2025 IPEV Valuation Guidelines require the valuation to be calibrated to that transaction price. Calibration means adjusting the valuation model inputs so that the model output equals the transaction price at the transaction date — then rolling forward to the current measurement date using updated financial performance, market conditions, and company-specific developments. The transaction price is not automatically fair value at subsequent dates; it is a starting point that must evolve.

Cost Approach / Price of Recent Investment — For very early-stage companies with limited financial history, the price of the most recent financing round may approximate fair value — but only if no significant events have occurred since that round. The 2025 IPEV Guidelines emphasise that this approach has inherent limitations and should be supplemented with qualitative and quantitative analysis of developments since the investment date.

Equity Allocation — Waterfall and Option Pricing Models

Once enterprise value is determined, it must be allocated across the portfolio company’s capital structure to determine the fair value of the specific class of equity held by the fund. This is critical because preference shares, ordinary shares, and other equity classes have different economic rights — liquidation preferences, participation features, conversion ratios, anti-dilution protections — that directly affect their respective fair values.

Waterfall Analysis (Current Value Method) — Distributes the estimated enterprise value across each class of equity in order of liquidation priority. Most appropriate when a near-term liquidity event is expected or when the company’s value is close to or below the aggregate liquidation preferences.

Option Pricing Method (OPM) — Treats each class of equity as a call option on the enterprise value with different strike prices (defined by the liquidation preferences). Uses a Black-Scholes framework to allocate value, incorporating expected time to liquidity and volatility. Most appropriate for early-to-mid-stage companies where a liquidity event is uncertain and the capital structure is complex.

OPM Backsolve — A variant that calibrates the OPM to the price of a recent financing round (the “known” data point) to solve for the implied enterprise value, then applies that calibrated model to determine the fair value of all other equity classes. Widely used in venture capital and growth equity portfolios.

Hybrid Methods — Probability-weighted combinations of the waterfall and OPM approaches, used when multiple liquidity scenarios (IPO, trade sale, continuation) have meaningfully different probabilities and timing.

Debt & Credit Investment Valuations

For credit-focused funds, listed investment companies, CLO vehicles, and funds holding mezzanine or structured debt, AASB 13 requires fair value measurement of debt instruments that often lack active secondary markets.

Valuation Approaches for Debt Instruments

Discounted Cash Flow / Yield Analysis — Projects contractual cash flows (interest, principal, fees) and discounts them at a market-participant required yield. The discount rate reflects current market yields for instruments with comparable credit risk, tenor, seniority, and collateral — not the contractual coupon rate.

Market Approach — Comparable Transactions — Uses observed yields or prices from secondary market transactions in comparable debt instruments (similar credit quality, industry, structure) to benchmark the fair value of the fund’s holdings.

Enterprise Value Coverage Analysis — For debt secured by the enterprise value of the borrower, the valuation assesses whether the estimated enterprise value provides sufficient coverage for the debt position. When coverage is tight, the debt may trade below par; when coverage is ample, the debt may be valued at or near par (adjusted for yield).

Key Considerations for Credit Portfolios

Credit Quality Changes — Deterioration or improvement in the borrower’s financial condition since origination directly affects fair value. Auditors expect the valuation to reflect current credit metrics, not origination-date underwriting.

PIK and Deferred Interest — Payment-in-kind features, capitalised interest, and other non-cash accruals must be incorporated into the fair value analysis, reflecting market-participant expectations about ultimate collectability.

Unit of Account — AASB 13 requires careful consideration of the unit of account. When a fund holds both equity and debt in the same portfolio company, each instrument is generally valued separately based on its specific rights and priority in the capital structure.

The 2025 IPEV Valuation Guidelines — What Changed

The International Private Equity and Venture Capital Valuation (IPEV) Board published updated guidelines in 2025, and these are now the global best-practice framework referenced by auditors, regulators, and institutional investors alongside AASB 13. The Australian Investment Council endorses IPEV as the valuation standard for the local private capital industry. Key updates relevant to 2026 portfolio valuations include:

Calibration Is Not Optional — The 2025 guidelines reinforce that fair value must evolve from one measurement date to the next. The price of a recent investment is not automatically fair value at subsequent reporting dates. Funds must demonstrate how they have calibrated to the transaction and then adjusted for changes in performance, market conditions, and company-specific events.

ESG Integration — The updated guidelines require that environmental, social, and governance factors be integrated quantitatively into fair value analysis where they have a material impact on value — not just referenced qualitatively.

Enhanced Disclosure Expectations — Greater emphasis on transparency in valuation processes, governance frameworks, and the documentation trail supporting each fair value conclusion.

Expanded Guidance on Complex Structures — Additional guidance on valuing structured instruments, earn-outs, milestone-based payments, and hybrid securities commonly found in venture capital and growth equity portfolios.

InteleK’s valuation methodology is fully aligned with both AASB 13 and the 2025 IPEV Guidelines, ensuring your portfolio valuations meet the expectations of Australian and international auditors and investors alike.

ASIC & Regulatory Scrutiny — The 2026 Landscape

Portfolio valuations are not just an accounting exercise — they are a regulatory compliance obligation. ASIC has identified valuation of unlisted and illiquid assets as a focus area for private market funds and superannuation trustees, and APRA applies parallel expectations to RSE licensees under Prudential Standard SPS 530 (Investment Governance), which requires trustees to have a documented valuation framework, independent oversight, and revaluation triggers for unlisted assets.

What ASIC and APRA Are Looking For:

  • Consistency of valuation methodology across reporting periods — and documented justification for any changes
  • Independence and qualifications of the valuation specialist
  • Whether the fund’s valuation policy is actually followed in practice — not just documented on paper
  • Adequacy of valuation governance, including the role and independence of the valuation committee
  • Whether valuations reflect current market conditions or are stale / anchored to outdated inputs
  • Proper classification within the AASB 13 fair value hierarchy and adequate Level 3 disclosures
  • For registered schemes, unit pricing practices consistent with ASIC RG 94 and equitable treatment of investors entering and exiting the fund

Regulatory Context: ASIC’s review of Australia’s private markets has put valuation practices, governance, and disclosure to investors squarely in scope, and APRA’s reviews of unlisted asset valuation governance have driven material uplift in trustee revaluation frameworks. An independent, well-documented portfolio valuation from an accredited specialist is the strongest defence against regulatory challenge.

InteleK’s Portfolio Valuation Approach

Our accredited valuers bring deep AASB 13 and IPEV compliance experience to every portfolio valuation engagement. Here’s what sets our process apart:

Audit-Ready Deliverables From Day 1 — Every valuation memo is structured and documented to satisfy the requirements of Big Four, mid-tier, and national audit firms. We understand what auditors test — because we’ve been through the review process hundreds of times — and we build that standard into every engagement.

Full Suite of Valuation Methodologies — We apply Market, Income, and Cost approaches as appropriate, with rigorous calibration to recent transactions. Our equity allocation expertise spans waterfall analysis, OPM, OPM backsolve, and hybrid methods — ensuring the right tool is applied to each portfolio company’s capital structure and stage.

Calibration-First Philosophy — Consistent with AASB 13 and the 2025 IPEV Guidelines, every subsequent-period valuation begins with calibration to the most recent arm’s-length transaction, then systematically adjusts for changes in performance, market conditions, and company-specific events. Every adjustment is documented and defensible.

Debt & Credit Expertise — Our team values the full spectrum of credit instruments — senior secured, mezzanine, unitranche, PIK, convertible notes, and structured securities — using yield analysis, enterprise value coverage, and market-comparable approaches tailored to the specific instrument’s terms.

AASB 13 Fair Value Hierarchy Compliance — All Level 3 measurements include detailed disclosure of significant unobservable inputs, the valuation techniques applied, and sensitivity analyses — meeting the AASB 13 disclosure requirements (paragraphs 91–99) and giving your auditor a clear path to their own assessment.

Scalable for Large Portfolios — Whether your fund holds 5 investments or 50, our process is designed to deliver consistent, high-quality valuations across the entire portfolio within your reporting timeline. We manage engagement timelines to align with your periodic close and annual audit schedule.

Collaboration With Your Fund Team — We work alongside your CFO, financial controller, fund administrator, auditor, and valuation committee to ensure the valuations integrate seamlessly into your reporting workflow and governance framework.

Portfolio Valuation (AASB 13) FAQs

Expert insights into AASB 13 fair value measurement for private equity, venture capital, and credit fund portfolio investments in 2026.

⚠️ General information only. InteleK Business Valuations & Advisory Pty Ltd recommends professional accounting, tax and legal advice for all financial reporting matters.

Search 2026 Portfolio Valuation & AASB 13 Topics
AASB 13 (Fair Value Measurement) is the Australian Accounting Standard that defines fair value, establishes a framework for measuring it, and sets disclosure requirements. For private equity, venture capital, and credit funds, AASB 13 requires every portfolio investment to be measured at its exit price — the price a knowledgeable, willing market participant would pay today — not what the fund originally paid. This standard governs your audited financial statements, unit pricing and NAV reporting, and investor statements, making it the foundation of your fund's reported performance.
Portfolio investments must be measured at fair value whenever the fund reports financial results under Australian Accounting Standards. In practice, this means at least annually for audited financial statements, which registered managed investment schemes must lodge with ASIC under Chapter 2M of the Corporations Act. Most institutional-quality funds also require periodic fair value updates for unit pricing, NAV reporting, and investor statements. Additionally, material events — such as a new financing round, significant operational change, or market dislocation — may trigger interim revaluations between regular reporting periods.
AASB 13 establishes three levels of inputs. Level 1 uses quoted prices in active markets for identical assets (listed securities). Level 2 uses observable inputs like quoted prices for similar assets or market-corroborated data (certain syndicated loans, traded debt). Level 3 uses unobservable inputs reflecting the entity's own market-participant assumptions. The vast majority of private equity, venture capital, and credit fund investments are classified as Level 3 — requiring sophisticated valuation models, well-documented assumptions, and the highest degree of audit and regulatory scrutiny.
Calibration is the process of adjusting valuation model inputs so that the model output equals the price of a recent arm's-length transaction at the transaction date — then rolling forward to the current measurement date using updated financial performance, market conditions, and company-specific developments. Both AASB 13 and the 2025 IPEV Valuation Guidelines require calibration. The transaction price is not automatically fair value at subsequent dates; it is a starting point that must evolve. Auditors focus heavily on calibration because it demonstrates that the valuation is anchored to observable market evidence.
The most common approaches include the Market Approach (applying EV/Revenue, EV/EBITDA, or EV/Gross Profit multiples from comparable listed companies or M&A transactions), the Income Approach (discounted cash flow analysis), and calibration to the price of a recent investment. For very early-stage companies with limited financial history, the cost approach or price of the most recent financing round may approximate fair value — but only if no significant events have occurred since that round. The appropriate method depends on the portfolio company's stage, industry, and available data.
Once enterprise value is estimated, it must be allocated across the portfolio company's capital structure to determine the fair value of the specific class of equity the fund holds. Preference shares, ordinary shares, and other classes have different economic rights — liquidation preferences, participation features, conversion ratios, anti-dilution protections — that directly affect their respective fair values. Allocation methods include the waterfall analysis (current value method), the Option Pricing Method (OPM), OPM backsolve, and hybrid probability-weighted approaches. Selecting the wrong allocation method can materially misstate the fair value of your fund's holdings.
The OPM treats each class of equity as a call option on the enterprise value, with different strike prices defined by the liquidation preferences. It uses a Black-Scholes framework incorporating expected time to liquidity and volatility to allocate value across the capital structure. The OPM is most appropriate for early-to-mid-stage companies where a liquidity event is uncertain and the capital structure is complex. The OPM backsolve variant calibrates the model to the price of a recent financing round to solve for implied enterprise value, then determines the fair value of all other equity classes.
Debt instruments that lack active secondary markets are valued using discounted cash flow / yield analysis (projecting contractual cash flows and discounting at a market-participant required yield), comparable transaction pricing (benchmarking against observed yields on similar instruments), and enterprise value coverage analysis (assessing whether the borrower's enterprise value provides sufficient coverage). Key considerations include credit quality changes since origination, PIK and deferred interest features, and the specific seniority and collateral securing the instrument.
The 2025 IPEV Guidelines — the global best-practice framework referenced by auditors and institutional investors alongside AASB 13, and endorsed by the Australian Investment Council for the local private capital industry — reinforced several key principles: calibration is not optional and fair value must evolve from one measurement date to the next; ESG factors must be integrated quantitatively into fair value analysis where material; enhanced disclosure and documentation expectations for valuation processes and governance; and expanded guidance on valuing complex structures including earn-outs, milestone-based payments, and hybrid securities common in VC and growth equity portfolios.
The unit of account determines what is being measured — a critical concept when a fund holds multiple tranches of investment in the same portfolio company. Under AASB 13, when a fund holds both equity and debt in the same company, each instrument is generally valued separately based on its specific rights and priority in the capital structure. The unit of account also determines whether block discounts or portfolio-level adjustments are appropriate — noting that AASB 13 expressly prohibits block discounts for Level 1 measurements. Auditors scrutinise unit of account determinations because they can materially affect the reported fair value of individual holdings.
Yes. ASIC has flagged the valuation of unlisted and illiquid assets as a focus area in its review of Australia's private markets, and APRA applies parallel expectations to superannuation trustees under Prudential Standard SPS 530 (Investment Governance). Regulators look at consistency of methodology across reporting periods, independence and qualifications of the valuation specialist, whether the fund's valuation policy is actually followed in practice, adequacy of valuation governance and committee independence, whether valuations reflect current market conditions or are anchored to stale inputs, revaluation triggers between reporting dates, and proper AASB 13 hierarchy classification with adequate Level 3 disclosures. An independent, well-documented portfolio valuation is the strongest defence.
Overstating values inflates reported performance metrics (IRR, TVPI), overstates management and performance fees, and can trigger ASIC enforcement action, investor disputes, and breaches of the responsible entity's or trustee's duties under the Corporations Act. Understating values shortchanges fund economics, misrepresents returns to prospective investors, and creates inequity between investors entering and exiting the fund at published unit prices. Both directions create legal, regulatory, and reputational risk. The goal is an accurate, defensible fair value conclusion — not an optimistic or conservative one.
Auditors test the reasonableness of every material Level 3 fair value measurement under ASA 540 (Auditing Accounting Estimates). They evaluate whether the valuation methodology is appropriate for the investment type, whether assumptions (multiples, discount rates, volatility, time to exit) are supported by market data, whether calibration to recent transactions was properly performed, whether the equity allocation method matches the capital structure and expected liquidity scenario, and whether the documentation is sufficient to independently reproduce the conclusion. ASIC's audit inspection program consistently cites fair value of non-financial and unlisted assets as a leading area of audit deficiency.
Not automatically. While the price of a recent arm's-length financing round is a relevant data point, AASB 13 and the 2025 IPEV Guidelines are clear that the transaction price is not automatically fair value at subsequent measurement dates. You must assess whether significant events have occurred since the round — changes in financial performance, market conditions, capital structure, or company-specific developments — and adjust accordingly. Auditors will challenge any valuation that simply carries forward a stale round price without documented analysis of intervening changes.
Auditors, investors, and regulators increasingly expect independent, third-party valuation support for Level 3 portfolio investments — particularly given the inherent conflict of interest when a fund manager values its own portfolio. An accredited specialist (CA ANZ Business Valuation Specialist, CPA, or CFA) brings objectivity, technical rigour, and defensibility that strengthens your financial reporting and satisfies your valuation committee, auditor, and investor due diligence requirements. InteleK's work product is designed to satisfy Big Four, mid-tier, and national audit firm requirements from Day 1.
No portfolio valuation topics found matching your search. Try keywords like "AASB 13", "Level 3", "calibration", "OPM", "IPEV", or "audit".